logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Anderson, Richard James
    Born in April 1966
    Individual (21 offsprings)
    Officer
    icon of calendar 2020-04-03 ~ now
    OF - Director → CIF 0
    Mr Richard James Anderson
    Born in April 1966
    Individual (21 offsprings)
    Person with significant control
    icon of calendar 2020-04-03 ~ now
    PE - Right to appoint or remove directors → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
Ceased 1
  • Kerry, Spencer Alan
    Director born in September 1974
    Individual
    Officer
    icon of calendar 2020-04-03 ~ 2022-09-28
    OF - Director → CIF 0
    Mr Spencer Alan Kerry
    Born in September 1974
    Individual
    Person with significant control
    icon of calendar 2020-04-03 ~ 2022-09-28
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

CANUTE PHARMA LIMITED

Previous names
CANUTE PHARMA LIMITED - 2024-10-04
DERM NEWCO LIMITED - 2020-05-28
BRAEMAR PHARMA LTD - 2024-11-20
Standard Industrial Classification
32500 - Manufacture Of Medical And Dental Instruments And Supplies
Brief company account
Par Value of Share
Class 1 ordinary share
12023-04-01 ~ 2024-03-31
Class 2 ordinary share
12023-04-01 ~ 2024-03-31
Class 3 ordinary share
12023-04-01 ~ 2024-03-31
Intangible Assets
207,660 GBP2024-03-31
417,889 GBP2023-03-31
Property, Plant & Equipment
1,928 GBP2024-03-31
3,567 GBP2023-03-31
Fixed Assets - Investments
2 GBP2024-03-31
2 GBP2023-03-31
Fixed Assets
209,590 GBP2024-03-31
421,458 GBP2023-03-31
Total Inventories
113,781 GBP2024-03-31
97,206 GBP2023-03-31
Debtors
739,759 GBP2024-03-31
644,146 GBP2023-03-31
Cash at bank and in hand
11,022 GBP2024-03-31
94,364 GBP2023-03-31
Current Assets
864,562 GBP2024-03-31
835,716 GBP2023-03-31
Creditors
Current
743,961 GBP2024-03-31
749,892 GBP2023-03-31
Net Current Assets/Liabilities
120,601 GBP2024-03-31
85,824 GBP2023-03-31
Total Assets Less Current Liabilities
330,191 GBP2024-03-31
507,282 GBP2023-03-31
Creditors
Non-current
1,169,666 GBP2024-03-31
1,477,212 GBP2023-03-31
Net Assets/Liabilities
-839,475 GBP2024-03-31
-969,930 GBP2023-03-31
Equity
Called up share capital
100 GBP2024-03-31
100 GBP2023-03-31
Retained earnings (accumulated losses)
-839,575 GBP2024-03-31
-970,030 GBP2023-03-31
Equity
-839,475 GBP2024-03-31
-969,930 GBP2023-03-31
Average Number of Employees
62023-04-01 ~ 2024-03-31
82022-04-01 ~ 2023-03-31
Intangible Assets - Gross Cost
Net goodwill
222,468 GBP2023-03-31
Other than goodwill
1,802,123 GBP2023-03-31
Intangible Assets - Gross Cost
2,024,591 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
167,014 GBP2024-03-31
122,477 GBP2023-03-31
Other than goodwill
1,649,917 GBP2024-03-31
1,484,225 GBP2023-03-31
Intangible Assets - Accumulated Amortisation & Impairment
1,816,931 GBP2024-03-31
1,606,702 GBP2023-03-31
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
44,537 GBP2023-04-01 ~ 2024-03-31
Other than goodwill
165,692 GBP2023-04-01 ~ 2024-03-31
Intangible Assets - Increase From Amortisation Charge for Year
210,229 GBP2023-04-01 ~ 2024-03-31
Intangible Assets
Net goodwill
55,454 GBP2024-03-31
99,991 GBP2023-03-31
Other than goodwill
152,206 GBP2024-03-31
317,898 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Furniture and fittings
14,507 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Furniture and fittings
12,579 GBP2024-03-31
10,940 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Furniture and fittings
1,639 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Furniture and fittings
1,928 GBP2024-03-31
3,567 GBP2023-03-31
Investments in Group Undertakings
Cost valuation
2 GBP2023-03-31
Investments in Group Undertakings
2 GBP2024-03-31
2 GBP2023-03-31
Trade Debtors/Trade Receivables
Amounts falling due within one year, Current
178,146 GBP2024-03-31
136,012 GBP2023-03-31
Amounts Owed by Group Undertakings
Current
273,128 GBP2024-03-31
127,372 GBP2023-03-31
Other Debtors
Amounts falling due within one year, Current
87,746 GBP2024-03-31
110,536 GBP2023-03-31
Debtors
Amounts falling due within one year, Current
539,020 GBP2024-03-31
373,920 GBP2023-03-31
Other Debtors
Amounts falling due after one year, Non-current
200,739 GBP2024-03-31
270,226 GBP2023-03-31
Bank Borrowings/Overdrafts
Current
271,940 GBP2024-03-31
310,725 GBP2023-03-31
Trade Creditors/Trade Payables
Current
274,795 GBP2024-03-31
245,405 GBP2023-03-31
Other Taxation & Social Security Payable
Current
12,663 GBP2024-03-31
10,599 GBP2023-03-31
Other Creditors
Current
184,563 GBP2024-03-31
183,163 GBP2023-03-31
Bank Borrowings/Overdrafts
Non-current
102,504 GBP2024-03-31
397,052 GBP2023-03-31
Other Creditors
Non-current
1,067,162 GBP2024-03-31
1,080,160 GBP2023-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
60 shares2024-03-31
Class 2 ordinary share
30 shares2024-03-31
Class 3 ordinary share
10 shares2024-03-31
Related profiles found in government register
  • CANUTE PHARMA LIMITED
    Info
    CANUTE PHARMA LIMITED - 2024-10-04
    DERM NEWCO LIMITED - 2024-10-04
    BRAEMAR PHARMA LTD - 2024-10-04
    Registered number 12545506
    icon of addressGround Floor, 3 Royal Court, Tatton Street, Knutsford, Cheshire WA16 6EN
    PRIVATE LIMITED COMPANY incorporated on 2020-04-03 (5 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-02
    CIF 0
  • CANUTE PHARMA LIMITED
    S
    Registered number 12545506
    icon of addressGround Floor, 3 Royal Court, Tatton Street, Knutsford, Cheshire, England, WA16 6EN
    Private Limited Company in Companies House, England And Wales
    CIF 1
child relation
Offspring entities and appointments
Active 1
  • icon of address12 Rutherford Drive, Knutsford, England
    Active Corporate (3 parents)
    Equity (Company account)
    113,010 GBP2024-03-31
    Person with significant control
    icon of calendar 2020-06-09 ~ now
    CIF 1 - Right to appoint or remove directors → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Ownership of shares – 75% or more → OE

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.